1140 related articles for article (PubMed ID: 19082859)
21. Impact of the peritoneal surface disease severity score on survival in patients with colorectal cancer peritoneal carcinomatosis undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy.
Chua TC; Morris DL; Esquivel J
Ann Surg Oncol; 2010 May; 17(5):1330-6. PubMed ID: 20033321
[TBL] [Abstract][Full Text] [Related]
22. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy.
Feldman AL; Libutti SK; Pingpank JF; Bartlett DL; Beresnev TH; Mavroukakis SM; Steinberg SM; Liewehr DJ; Kleiner DE; Alexander HR
J Clin Oncol; 2003 Dec; 21(24):4560-7. PubMed ID: 14673042
[TBL] [Abstract][Full Text] [Related]
23. Significance of lymph node metastasis in patients with diffuse malignant peritoneal mesothelioma.
Yan TD; Yoo D; Sugarbaker PH
Eur J Surg Oncol; 2006 Nov; 32(9):948-53. PubMed ID: 16806796
[TBL] [Abstract][Full Text] [Related]
24. Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms.
Yan TD; Bijelic L; Sugarbaker PH
Ann Surg Oncol; 2007 Aug; 14(8):2289-99. PubMed ID: 17541772
[TBL] [Abstract][Full Text] [Related]
25. Combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for the treatment of malignant peritoneal mesothelioma.
Hesdorffer ME; Chabot JA; Keohan ML; Fountain K; Talbot S; Gabay M; Valentin C; Lee SM; Taub RN
Am J Clin Oncol; 2008 Feb; 31(1):49-54. PubMed ID: 18376228
[TBL] [Abstract][Full Text] [Related]
26. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience.
Chua TC; Yan TD; Morris DL
J Surg Oncol; 2009 Feb; 99(2):109-13. PubMed ID: 19016259
[TBL] [Abstract][Full Text] [Related]
27. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases.
Yang XJ; Li Y; al-shammaa Hassan AH; Yang GL; Liu SY; Lu YL; Zhang JW; Yonemura Y
Ann Surg Oncol; 2009 Feb; 16(2):345-51. PubMed ID: 19018599
[TBL] [Abstract][Full Text] [Related]
28. Cytoreduction and hyperthermic intraperitoneal chemoperfusion in women with heavily pretreated recurrent ovarian cancer.
Ceelen WP; Van Nieuwenhove Y; Van Belle S; Denys H; Pattyn P
Ann Surg Oncol; 2012 Jul; 19(7):2352-9. PubMed ID: 20039210
[TBL] [Abstract][Full Text] [Related]
29. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer.
Di Giorgio A; Naticchioni E; Biacchi D; Sibio S; Accarpio F; Rocco M; Tarquini S; Di Seri M; Ciardi A; Montruccoli D; Sammartino P
Cancer; 2008 Jul; 113(2):315-25. PubMed ID: 18473354
[TBL] [Abstract][Full Text] [Related]
30. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
[TBL] [Abstract][Full Text] [Related]
31. Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal metastases.
Chua TC; Quinn LE; Zhao J; Morris DL
J Surg Oncol; 2013 Aug; 108(2):81-8. PubMed ID: 23737041
[TBL] [Abstract][Full Text] [Related]
32. Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis: clinical outcome and prognostic factors in 60 consecutive patients.
Rossi CR; Deraco M; De Simone M; Mocellin S; Pilati P; Foletto M; Cavaliere F; Kusamura S; Gronchi A; Lise M
Cancer; 2004 May; 100(9):1943-50. PubMed ID: 15112276
[TBL] [Abstract][Full Text] [Related]
33. Toxicity and outcomes associated with surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with sarcomatosis.
Lim SJ; Cormier JN; Feig BW; Mansfield PF; Benjamin RS; Griffin JR; Chase JL; Pisters PW; Pollock RE; Hunt KK
Ann Surg Oncol; 2007 Aug; 14(8):2309-18. PubMed ID: 17541691
[TBL] [Abstract][Full Text] [Related]
34. Peritoneal sarcomatosis: is there a subset of patients who may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy?
Baratti D; Pennacchioli E; Kusamura S; Fiore M; Balestra MR; Colombo C; Mingrone E; Gronchi A; Deraco M
Ann Surg Oncol; 2010 Dec; 17(12):3220-8. PubMed ID: 20585874
[TBL] [Abstract][Full Text] [Related]
35. Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results.
Golse N; Bakrin N; Passot G; Mohamed F; Vaudoyer D; Gilly FN; Glehen O; Cotte E
J Surg Oncol; 2012 Aug; 106(2):197-203. PubMed ID: 22331814
[TBL] [Abstract][Full Text] [Related]
36. Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations.
Pelz JO; Doerfer J; Dimmler A; Hohenberger W; Meyer T
BMC Cancer; 2006 Jun; 6():162. PubMed ID: 16792796
[TBL] [Abstract][Full Text] [Related]
37. Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma.
Yan TD; Brun EA; Cerruto CA; Haveric N; Chang D; Sugarbaker PH
Ann Surg Oncol; 2007 Jan; 14(1):41-9. PubMed ID: 17039392
[TBL] [Abstract][Full Text] [Related]
38. Risk factors and clinicopathological study of prognostic factors in the peritoneal mesothelioma.
Tudor EC; Chua TC; Liauw W; Morris DL
Am Surg; 2010 Apr; 76(4):400-5. PubMed ID: 20420251
[TBL] [Abstract][Full Text] [Related]
39. Role of explorative laparoscopy to evaluate optimal candidates for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal mesothelioma.
Laterza B; Kusamura S; Baratti D; Oliva GD; Deraco M
In Vivo; 2009; 23(1):187-90. PubMed ID: 19368148
[TBL] [Abstract][Full Text] [Related]
40. Long-term survival of peritoneal carcinomatosis of colorectal origin.
Verwaal VJ; van Ruth S; Witkamp A; Boot H; van Slooten G; Zoetmulder FA
Ann Surg Oncol; 2005 Jan; 12(1):65-71. PubMed ID: 15827780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
